Top Industry Leaders in the Eye Allergy Treatment Market
Latest Eye Allergy Treatment Companies Updates:
Bausch + Lomb acquires Akorn's ophthalmic business: This December 2023 deal strengthens Bausch + Lomb's eye care portfolio by adding Akorn's expertise in sterile ophthalmic medications, including allergy treatments.
Alcon collaborates with Clearside Biomedical: This partnership leverages Clearside's nano-technology platform to develop next-generation eye drops with improved drug delivery and efficacy for allergy relief.
Novartis unveils Iluvium™: This novel prescription eye drop offers sustained relief from eye itching, a major symptom of allergic conjunctivitis.Allergan introduces Pataday Air Optive™: These prescription eye drops combine antihistamine and mast cell stabilizer medications in a convenient single-dose format for allergy relief.
List of Eye Allergy Treatment Key companies in the market:
- Pfizer Inc. (US)
- Regeneron Pharmaceuticals, Inc. (US)
- Hoffmann-La Roche Ltd (Switzerland)
- Santen Pharmaceutical Co., Ltd (Japan)
- Valeant (Canada)